Key Highlights
- Third quarter Revenue was USD 230.2 million versus USD 288.2 million, and Gross Profit was USD 148.0 million.
- Gross Margin was 64.3% versus 58.9%, and adjusted EBITDA was USD 89 million at a 39% margin.
- Capital expenditures were USD 29 million, and free Cash Flow totaled USD 45 million in the quarter.
- Full year 2026 Operating Cash Flow is projected at least USD 225 million, with capital expenditures near USD 105 million.
Trulieve Cannabis Corp. (NYSE:TRLV) reported third quarter 2026 revenue of USD 230.2 million, a decrease of USD 58.0 million from USD 288.2 million in the prior-year quarter. Nine-month revenue was USD 787.9 million versus USD 888.0 million.
Chief Executive Officer Kimberly Rivers and management described a quarter in which revenue trends improved sequentially, and said the company has adequate Supply for current Business while adding capacity in stages into 2027.
Margins, Expenses and Taxes
Cost of goods sold was USD 82.2 million, or 35.7% of revenue versus 41.1%. Gross profit was USD 148.0 million, or 64.3% of revenue versus 58.9%. Selling, general and administrative expense was USD 87.8 million, or 38.2% of revenue versus 34.4%, and Depreciation and amortization was USD 17.7 million versus USD 29.5 million.
Net interest expense was USD 12.0 million. Equity in the net loss of Harvest was USD 6.4 million, representing the company's share of Harvest's results after the June 3, 2026 Deconsolidation Transaction. The provision for income taxes was USD 26.3 million, or 17.7% of gross profit versus 31.2%, with the decrease driven by the company not applying IRC Section 280E for the 2026 taxable year.
Adjusted EBITDA was USD 89 million, a 39% margin, which management attributed to expense control in the core business.
Cash Flow, Markets and Digital
Third quarter capital expenditures were USD 29 million and free cash flow totaled USD 45 million. In June the company adopted a share repurchase program. For full year 2026, management projects operating cash flow of at least USD 225 million, and capital expenditures of approximately USD 105 million, up from USD 95 million, with increased Investment in growth markets.
More than half a million orders, or 30% of all online orders, were placed through the mobile app in the third quarter. The company plans to launch the app in Georgia soon, followed by additional markets in 2027.
Market Factors to Track
Management said it plans to introduce new Alien Labs and Connected categories and form factors in Florida, including vapes and concentrates, as soon as the first half of 2027, and expects efficiency and speed-to-market benefits to begin in the first quarter of 2027. It also described a planned Texas launch in 2027 and said 2027 is more capital intensive than recent years.
Management pointed to federal developments, including rescheduling of marijuana, SAFE Banking, updated FinCEN guidance and Treasury guidance on 280E tax treatment, as aligning federal policy with state licensed programs. Reported detail: Capital expenditures were USD 29 million, and free cash flow totaled USD 45 million in the quarter. Full year 2026 operating cash flow is projected at least USD 225 million, with capital expenditures near USD 105 million.


_11_20_2026_14_55_23_118425.jpg)



Please wait processing your request...